Results 121 to 130 of about 34,473 (219)

Sustained Tear Film Exposure After Parenteral Cefovecin Administration in Dogs: Pharmacokinetics and Relevance to Canine Bacterial Keratitis

Veterinary Ophthalmology, Volume 29, Issue 5, September 2026.
ABSTRACT Objective To characterize the tear film pharmacokinetics of parenterally administered cefovecin (Convenia) and compare tear concentrations with the minimum inhibitory concentrations (MICs) of common ocular pathogens. Animals Studied Six healthy research‐bred Beagles.
Meredith R. McClure, Lionel Sebbag, David J. Borts, Rachel A. Allbaugh, Jessica L. Payne, Melissa A. Kubai   +5 more
wiley   +1 more source

Voriconazole-induced periostitis

, 2019
In this case report, a 49-year-old man was diagnosed with influenza-associated invasive aspergillosis. Voriconazole therapy was initiated and adjusted to meet therapeutic range.
Katzenstein, Terese Lea, Justad, Bjarte Aspenes, Helweg-Larsen, Jannik, Jakobsen, Ditte Marie   +3 more
core   +1 more source

Voriconazole-Induced acute interstitial pulmonary edema with angioedema: A case report

BMC Pulmonary Medicine
Background Voriconazole is a first-line antifungal agent for invasive fungal infections. Reports of voriconazole-induced interstitial pulmonary edema are exceedingly rare.
Yuzhen Jin, Lijie Qin, Peng Liu, Zhaoxia Song, Mengjie Li   +4 more
doaj   +1 more source

Peer review of the pesticide risk assessment of the active substance Beauveria bassiana strain R444

EFSA Journal, Volume 24, Issue 9, September 2026.
Abstract The conclusions of the EFSA following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State, Denmark, for the pesticide active substance Beauveria bassiana strain R444 and the considerations as regards the inclusion of the substance in Annex IV of Regulation (EC) No 396/2005 are ...
European Food Safety Authority (EFSA), Fernando Álvarez, Maria Arena, Domenica Auteri, Sofia Batista Leite, Marco Binaglia, Anna Federica Castoldi, Arianna Chiusolo, Angelo Colagiorgi, Mathilde Colas, Federica Crivellente, Chloe De Lentdecker, Isabella De Magistris, Mark Egsmose, Gabriella Fait, Franco Ferilli, German Giner Santonja, Varvara Gouliarmou, Alessio Ippolito, Frederique Istace, Dimitra Kardassi, Aude Kienzler, Anna Lanzoni, Roberto Lava, Renata Leuschner, Alberto Linguadoca, Mariano Lopez Romano, Jochem Louisse, Christopher Lythgo, Oriol Magrans, Iris Mangas, Silvia Mazzega, Andrea Mioč, Ileana Miron, Tunde Molnar, Laura Padovani, Vincenzo Padricello, Martina Panzarea, Juan Manuel Parra Morte, Simone Rizzuto, Miguel Santos, Rositsa Serafimova, Rachel Sharp, Csaba Szentes, Anne Theobald, Manuela Tiramani, Giorgia Vianello, Laura Villamar‐Bouza   +47 more
wiley   +1 more source

Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis

, 2018
Javier Martínez-Casanova,1 Nuria Carballo,1 Sonia Luque,1 Luisa Sorli,2 Santiago Grau1 1Pharmacy Department, Hospital del Mar, Barcelona, Spain; 2Infectious Diseases Department, Hospital del Mar, Barcelona, Spain Abstract: Azole antifungals have ...
Santiago Grau, Luque S, Carballo Martínez, Núria, Sorli Redó, M. Luisa, Luisa Sorli, Javier Martínez-Casanova, Grau S, Carballo N, Martínez-Casanova J, Sorli L, Luque Pardos, Sònia, Sonia Luque, Martínez-Casanova, Javier, Grau Cerrato, Santiago, Nuria Carballo   +14 more
core   +1 more source

A Retrospective, Comparative Cohort Analysis of the Utilization of Voriconazole-Containing Regimens Versus Itraconazole in the Treatment of Blastomycosis

Journal of Fungi
Itraconazole is the recommended first-line antifungal agent in blastomycosis treatment. However, pharmacokinetic limitations and adverse drug events may necessitate the use of alternative antifungal agents.
Caitlin C. Schanz, Christina G. Rivera, Omar M. Abu Saleh, Josh Clement, Mark J. Enzler, Danielle Firkus, Kristin Cole, Paschalis Vergidis, Ryan W. Stevens   +8 more
doaj   +1 more source

Voriconazole is rapidly incorporated.

, 2013
Arabidopsis seedlings were incubated for the indicated periods of time in ATS media supplemented with 25 µM voriconazole and the in situ contents of voriconazole were quantified by HPLC-DAD analysis. The means and standard deviations were calculated from
Wilfried Schwab (52238), Markus Idlhammer (102813), Wilfried Rozhon (102805), Mamoona Khan (102810), Daria Shumilina (102816), Thomas Hoffmann (102821), Brigitte Poppenberger (102826), Sigrid Husar (102806), Theo Lange (102818), Shozo Fujioka (102824), Florian Kalaivanan (102808)   +10 more
core   +1 more source

Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico

, 2018
Rayo Morfín-Otero,1,2 Martha Alvarado-Ibarra,3 Eduardo Rodriguez-Noriega,1,2 Jesus Resendiz-Sanchez,4 Dipen A Patel,5 Jennifer M Stephens,5 Manuela Di Fusco,6 Carlos F Mendoza,6 Claudie Charbonneau7 1Institute of Infectious and Experimental ...
Stephens JM, Morfín-Otero R, Di Fusco M, Rodriguez-Noriega E, Alvarado-Ibarra M, Resendiz-Sanchez J, Patel DA, Mendoza CF, Charbonneau C   +8 more
core  

Voriconazole Treatment Schedule.

, 2013
Voriconazole Treatment Schedule.
Joris Veltman (431438), Jordan Dimitrakoff (431442), Adam P. Fagin (147181), Theo S. Plantinga (164719), Emeric F. Bojarski (431436), Mihai G. Netea (105648), Alexander Hoischen (195016), Adam C. Strauss (431437), Victor J. Anciano Granadillo (431440), Stephen A. Allsop (431439), Arsani William (431441)   +10 more
core   +1 more source

Drug interactions with voriconazole

, 2015
Drug interactions are a potential problem with voriconazole therapy, due to the antifungal's extensive interaction with human cytochrome P450 enzymes and transporters.
VIALE, PIERLUIGI, LEWIS, RUSSEL EDWARD
core   +1 more source